A well-known MDM2-p53 PPI inhibitor - Nutlin had been employed to couple with an androgen receptor (AR) ligand to build a PROTAC, which resulted in the degradation of AR in prostate tumor cells18. The gene discussed is AR; the disease is prostate neoplasm.